Spruce Biosciences Inc SPRB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 9:30 AM EDT
0.7955quote price arrow down-0.0045 (-0.5625%)
Volume
5,073
52 week range
0.67 - 5.95
Loading...
  • Open0.781
  • Day High0.796
  • Day Low0.781
  • Prev Close0.80
  • 52 Week High5.95
  • 52 Week High Date03/08/24
  • 52 Week Low0.67
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap32.737M
  • Shares Out41.15M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.51
  • YTD % Change-72.7

KEY STATS

  • Open0.781
  • Day High0.796
  • Day Low0.781
  • Prev Close0.80
  • 52 Week High5.95
  • 52 Week High Date03/08/24
  • 52 Week Low0.67
  • 52 Week Low Date04/22/24
  • Market Cap32.737M
  • Shares Out41.15M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.51
  • YTD % Change-72.7

RATIOS/PROFITABILITY

  • EPS (TTM)-1.15
  • P/E (TTM)-0.69
  • Fwd P/E (NTM)-0.66
  • EBITDA (TTM)-51.361M
  • ROE (TTM)-53.55%
  • Revenue (TTM)10.127M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-461.67%
  • Debt To Equity (MRQ)4.42%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Spruce Biosciences Inc

 

Profile

MORE
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing therapies for rare endocrine disorders with significant unmet medical needs. The Company is initially developing its wholly owned product candidate, Tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). It is also developing Tildacerfont for females suffering from polycystic ovary syndrome...
Michael Grey
Executive Chairman of the Board
Javier Szwarcberg M.D.
Chief Executive Officer, Director
Samir Gharib CPA
President, Chief Financial Officer
Address
611 Gateway Boulevard, Suite 740
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
MRKR
Marker Therapeutics Inc
4.22+0.05+1.20%
DARE
Dare Bioscience Inc
0.403+0.043+11.9444%
BOLT
Bolt Biotherapeutics Inc
0.86+0.03+3.6145%
PTN
Palatin Technologies Inc
2.09+0.02+0.97%
TCON
TRACON Pharmaceuticals Inc
1.62UNCHUNCH